|
| |
| | | 00551 | | 04.10.1989 | | GlaxoSmithKline AG | | | | | | | | | | | | | 08.08. | | | | 08.08. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Engerix-B 10 | | Suspension () | J07BC01 | | | 03 | Engerix-B 10 | Injektionssuspension | Injection suspension (Hepatitidis b viri Antigenum Adnr 10µg / 0.5ml) | J07BC01 | | | 04 | Engerix B 10 | | (Vaccinum Hepatitidis b (Adnr) Hbsag 0.01 mg) | J07BC01 | |
|
|
|
